Agios Pharmaceuticals, Inc.
NASDAQ:AGIO
31.07 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||
| Current Assets: | ||||||||||||||
| Cash & Cash Equivalents
| 76.247 | 88.205 | 139.259 | 203.126 | 127.436 | 80.931 | 805.421 | 567.75 | 573.564 | 375.907 | 14.031 | 71.56 | 91.297 | 117.661 |
| Short Term Investments
| 817.463 | 688.723 | 643.86 | 816.892 | 445.493 | 483.946 | 514.8 | 321.212 | 380.56 | 245.238 | 328.034 | 95.209 | 36.679 | 61.507 |
| Cash and Short Term Investments
| 893.71 | 776.928 | 1,096.993 | 1,286.393 | 670.537 | 564.877 | 805.421 | 567.75 | 573.564 | 375.907 | 342.065 | 166.769 | 127.976 | 179.168 |
| Net Receivables
| 4.109 | 2.81 | 2.206 | 4.378 | 0 | 15.319 | 10.442 | 3.67 | 8.314 | 11.599 | 12.667 | 0.476 | 0 | 0 |
| Inventory
| 27.616 | 19.076 | 8.492 | 16.19 | 14.698 | 7.331 | 0.869 | -143.814 | -32.25 | -58.905 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 40.165 | 35.021 | 38.955 | 39.835 | 49.05 | 24.177 | 34.334 | 17.655 | 10.264 | 8.728 | 4.814 | 5.004 | 3.09 | 11.417 |
| Total Current Assets
| 965.6 | 833.835 | 832.772 | 1,064.231 | 636.677 | 611.704 | 613.78 | 445.261 | 559.892 | 337.329 | 359.546 | 169.747 | 130.144 | 190.585 |
| Non-Current Assets: | ||||||||||||||
| Property, Plant & Equipment, Net
| 54.554 | 69.791 | 88.116 | 104.23 | 117.542 | 126.108 | 24.32 | 24.431 | 25.337 | 23.22 | 6.386 | 3.758 | 3.565 | 3.222 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 29.435 | 313.874 | 266.375 | 97.608 | 152.929 | 220.119 | 143.814 | 32.25 | 58.905 | 125.382 | 27.125 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.706 | 0.037 |
| Other Non-Current Assets
| 643.045 | 4.057 | 3.956 | 2.9 | 1.125 | -279.037 | 0.238 | 0.891 | 1.615 | 0.611 | 0.59 | 0.575 | 0.593 | 0.626 |
| Total Non-Current Assets
| 697.599 | 103.283 | 405.946 | 373.505 | 216.275 | 279.037 | 244.677 | 169.136 | 59.202 | 82.736 | 132.358 | 31.458 | 6.864 | 3.885 |
| Total Assets
| 1,663.199 | 937.118 | 1,238.718 | 1,437.736 | 852.952 | 890.741 | 858.457 | 614.397 | 619.094 | 420.065 | 491.904 | 201.205 | 137.008 | 194.47 |
| Liabilities & Equity: | ||||||||||||||
| Current Liabilities: | ||||||||||||||
| Account Payables
| 16.643 | 9.78 | 18.616 | 16.7 | 17.724 | 21.896 | 17.88 | 22.767 | 17.106 | 14.748 | 11.067 | 3.678 | 3.308 | 3.573 |
| Short Term Debt
| 33.562 | 15.008 | 13.663 | 11.159 | 14.82 | 13.83 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0.871 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.841 | 1.462 | 4.875 | 17.867 |
| Deferred Revenue
| -16.781 | 0 | 0 | 0 | 0 | 10.933 | 92.519 | 163.64 | 190.21 | 24.364 | 35.686 | 25.072 | 25.072 | 25.072 |
| Other Current Liabilities
| 30.08 | 43.167 | 30.35 | 31.967 | 61.85 | 46.227 | 42.913 | 34.332 | 35.414 | 18.475 | 10.495 | 6.718 | 1.773 | 1.6 |
| Total Current Liabilities
| 81.156 | 67.955 | 62.629 | 59.826 | 94.394 | 92.886 | 93.503 | 94.941 | 88.433 | 52.888 | 61.089 | 36.93 | 35.113 | 48.158 |
| Non-Current Liabilities: | ||||||||||||||
| Long Term Debt
| 40.207 | 56.988 | 71.996 | 85.935 | 195.578 | 213.494 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 261.269 | 50.58 | 59.809 | 125.798 | 154.297 | 4.699 | 2.725 | 32.567 | 57.639 | 82.711 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | -261.269 | -50.58 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.88 | 1.156 | 3.279 | 0 | 163.48 | -106.747 | 17.608 | 18.155 | 17.773 | 17.36 | 3.724 | 0.226 | 0.015 | 0.033 |
| Total Non-Current Liabilities
| 41.087 | 58.144 | 75.275 | 85.935 | 359.058 | 157.327 | 77.417 | 143.953 | 172.07 | 22.059 | 6.449 | 32.793 | 57.997 | 83.172 |
| Total Liabilities
| 122.243 | 126.099 | 137.904 | 145.761 | 453.452 | 250.213 | 170.92 | 238.894 | 260.503 | 74.947 | 67.538 | 69.723 | 93.11 | 131.33 |
| Equity: | ||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 201.205 | 115.922 | 115.922 |
| Common Stock
| 0.073 | 0.072 | 0.071 | 0.071 | 0.069 | 0.068 | 0.058 | 0.049 | 0.042 | 0.038 | 0.037 | 0.031 | 0.003 | 0.003 |
| Retained Earnings
| -148.924 | -822.649 | -470.561 | -238.76 | -1,843.475 | -1,516.105 | -1,104.633 | -798.061 | -483.151 | -284.68 | -166.948 | -113.444 | -74.037 | -53.935 |
| Accumulated Other Comprehensive Income/Loss
| -1.518 | -0.441 | -12.535 | -1.198 | 0.105 | 0.202 | -2.171 | -1.389 | -0.313 | -0.318 | -0.057 | 0.014 | -0.002 | 0.023 |
| Other Total Stockholders Equity
| 1,691.325 | 1,634.037 | 1,583.839 | 1,531.862 | 2,242.801 | 2,156.363 | 1,794.283 | 1,174.904 | 842.013 | 630.078 | 591.334 | 244.881 | 2.012 | 1.127 |
| Total Shareholders Equity
| 1,540.956 | 811.019 | 1,100.814 | 1,291.975 | 399.5 | 640.528 | 687.537 | 375.503 | 358.591 | 345.118 | 424.366 | 131.482 | 43.898 | 63.14 |
| Total Equity
| 1,540.956 | 811.019 | 1,100.814 | 1,291.975 | 399.5 | 640.528 | 687.537 | 375.503 | 358.591 | 345.118 | 424.366 | 131.482 | 43.898 | 63.14 |
| Total Liabilities & Shareholders Equity
| 1,663.199 | 937.118 | 1,238.718 | 1,437.736 | 852.952 | 890.741 | 858.457 | 614.397 | 619.094 | 420.065 | 491.904 | 201.205 | 137.008 | 194.47 |